Jiwadaya Netraprabha Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-05-2024
- Paid Up Capital ₹ 0.10 M
as on 19-05-2024
- Company Age 37 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Jiwadaya Netraprabha Pharmaceutical Works
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anuj Shah, Vinit Shah, Dilip Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230MH1987PTC042721
- Company No.
042721
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1987
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jiwadaya Netraprabha Pharmaceutical Works?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Shah  | Managing Director | 26-Feb-1987 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anuj Shah | Director | 07-Apr-1998 | Current |
| Vinit Shah | Director | 07-Apr-1998 | Current |
| Dilip Shah | Director | 26-Feb-1987 | Current |
Financial Performance of Jiwadaya Netraprabha Pharmaceutical Works.
Jiwadaya Netraprabha Pharmaceutical Works Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jiwadaya Netraprabha Pharmaceutical Works?
In 2017, Jiwadaya Netraprabha Pharmaceutical Works had a promoter holding of 81.10% and a public holding of 18.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jiwadaya Healthcare Private LimitedActive 19 years 11 monthsAnuj Shah, Vinit Shah and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jiwadaya Netraprabha Pharmaceutical Works?
Unlock and access historical data on people associated with Jiwadaya Netraprabha Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jiwadaya Netraprabha Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jiwadaya Netraprabha Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
